D. Pittman

发表

Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIII.

A. Giles, R. Kaufman, K. Tomkinson, 1993, Blood.

The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human platelets.

A. Giles, M. Nesheim, R. Kaufman, 1991, The Journal of biological chemistry.

Role of the B domain for factor VIII and factor V expression and function.

R. Kaufman, D. Pittman, K. Marquette, 1994, Blood.

The binding of 35S-labeled recombinant factor VIII to activated and unactivated human platelets.

A. Giles, M. Nesheim, R. Kaufman, 1988, The Journal of biological chemistry.

Posttranslational sulfation of factor V is required for efficient thrombin cleavage and activation and for full procoagulant activity.

R. Kaufman, D. Michnick, K. Tomkinson, 1994, Biochemistry.

Identification of individual tyrosine sulfation sites within factor VIII required for optimal activity and efficient thrombin cleavage.

R. Kaufman, R. Kaufman, D. Michnick, 1994, The Journal of biological chemistry.

The factor V B-domain provides two functions to facilitate thrombin cleavage and release of the light chain.

R. Kaufman, D. Pittman, K. Marquette, 1995, Blood.

Structural Characterization of the Recombinant P40 Heavy Chain Subunit Monomer and Homodimer of Murine IL-12

J. E. Leonard, M. D. Bond, E. Nickbarg, 1995 .

Characterization of wild-type and Ser53 mutant eukaryotic initiation factor 4E overexpression in mammalian cells.

R. Kaufman, M. Davies, D. Pittman, 1993, The Journal of biological chemistry.

The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIII.

A. Dorner, R. Kaufman, R. Wise, 1991, The Journal of biological chemistry.

Identification and functional importance of tyrosine sulfate residues within recombinant factor VIII.

J. H. Wang, R. Kaufman, R. Kaufman, 1992, Biochemistry.

Post-translational requirements for functional factor V and factor VIII secretion in mammalian cells.

R. Kaufman, K. Tomkinson, D. Pittman, 1994, The Journal of biological chemistry.

A2 domain of human recombinant-derived factor VIII is required for procoagulant activity but not for thrombin cleavage.

K. Bauer, R. Kaufman, D. Pittman, 1992, Blood.

Proteolytic requirements for thrombin activation of anti-hemophilic factor (factor VIII).

R. Kaufman, D. Pittman, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Site-directed mutagenesis and expression of coagulation factors VIII and V in mammalian cells.

R. Kaufman, R. Kaufman, D. Pittman, 1993, Methods in enzymology.

Using a Systems Pharmacology Model of the Blood Coagulation Network to Predict the Effects of Various Therapies on Biomarkers

P Vicini, AC Heatherington, Steven W. Martin, 2015, CPT: pharmacometrics & systems pharmacology.

Cloning and expression in COS-1 cells of a full-length cDNA encoding human coagulation factor X.

T. Messier, G. Long, R. Kaufman, 1991, Gene.